about
Thyroid hormone receptor binding to DNA and T3-dependent transcriptional activation are inhibited by uremic toxinsA high red blood cell distribution width predicts failure of arteriovenous fistulaHemodialysis, erythropoietin and megakaryocytopoiesis: factors in uremic thrombocytopathy and thrombophilia.[Thrombocytopathy and blood complications in uremia].Subacute pulmonary embolism in a hemodialysis patient, successfully treated with surgical thrombectomyHigh prevalence of sickle cell trait in African Americans with ESRD.Higher recipient body mass index is associated with post-transplant delayed kidney graft function.Platelets of patients with chronic kidney disease demonstrate deficient platelet reactivity in vitro.Candidate Gene Analysis of Mortality in Dialysis PatientsUnexpected Normal Colloid Osmotic Pressure in Clinical States with Low Serum Albumin.Venous thromboembolism prevention in acutely ill nonsurgical patients.The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia.Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patientsSerum Indoxyl Sulfate Associates with Postangioplasty Thrombosis of Dialysis Grafts.Risk of Retinal Vein Occlusion Following End-Stage Renal Disease.Thrombin-anti-thrombin levels and patency of arterio-venous fistula in patients undergoing haemodialysis compared to healthy volunteers: a prospective analysis.Pretreatment with darbepoetin attenuates renal injury in a rat model of cisplatin-induced nephrotoxicityImpact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.Impact of Indoxyl Sulfate on Progenitor Cell-Related Neovascularization of Peripheral Arterial Disease and Post-Angioplasty Thrombosis of Dialysis Vascular Access.Medical complications in hemodialysis patients requiring vascular access radiology procedures.Biomarkers in atrial fibrillation: a clinical review.Considerations for Systemic Anticoagulation in ESRD.Antithrombotic medications in dialysis patients: a double-edged sword.Risk of pulmonary embolism in patients with end-stage renal disease receiving long-term dialysis.Platelet activation, coagulation activation and C-reactive protein in simultaneous samples from the vascular access and peripheral veins of haemodialysis patients.Deficiency of circulating progenitor cells associated with vascular thrombosis of hemodialysis patients.Exploring associations between anthropometric indices and graft function in patients receiving renal transplant.Does the oxidation of methionine in thrombomodulin contribute to the hypercoaguable state of smokers and diabetics?Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease.Pre-clinical model of severe glutathione peroxidase-3 deficiency and chronic kidney disease results in coronary artery thrombosis and depressed left ventricular function.Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk.Apolipoprotein and anticardiolipin antibodies in patients with renal amyloidosis.The comparative safety of abciximab versus eptifibatide in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).Uremic Solute-Aryl Hydrocarbon Receptor-Tissue Factor Axis Associates with Thrombosis after Vascular Injury in Humans.Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease.Thrombosis of tunneled-cuffed hemodialysis catheters: treatment with high-dose urokinase lock therapy.Increased risk of deep vein thrombosis in end-stage renal disease patients
P2860
Q24795393-E3CF5CBB-E1FB-45AA-9DAF-90A414939240Q28483360-D03BBE00-B593-4C5C-B1B0-99DF8C776E64Q33362092-466F3B58-7043-43A1-924D-DE97D6B71BE2Q33371562-F1A0A735-44CD-4579-B576-E6FF7EBE2FD2Q33622316-7064D2C0-2C49-40D6-8EAB-3E1177DB9387Q33702439-3087ADD4-3B84-41EE-BBA0-3CE42A4CF19FQ33848144-E123A86C-4940-4AE1-912F-5177956218B9Q34423730-9D29236F-CF02-4755-8502-5C94C692A72DQ35847012-09AC929E-057C-43DC-8D6B-749275B1F3A3Q36084415-0D9B7B4B-FEA1-4D49-8AA6-335C0D8F3D17Q36154876-5A2C55DC-EAFA-4908-B85E-77FD86E2AE95Q36417926-F55007D2-24CF-47AC-BE29-71A1D4D5D552Q36536307-384A7170-DDC0-4DF4-A2D9-1B599E68F16FQ36746081-CFEAF8C9-8019-4648-9DDC-D0418B1122E0Q36838150-37B5751B-C1BD-4C9D-BFE4-7F688486A5CAQ36976370-6BB7AF45-157E-4475-9B97-E6AD553C39B8Q37320966-AC37ABD6-D6F9-4BC7-936D-3484147399ECQ37322244-D7BB1445-BE5D-456F-B35D-ECF7DA45D1DBQ37641160-69DC94F6-00F6-4CA0-93BA-55FF6C028FE8Q37844414-A1D19702-7707-45C5-AF7B-DF314B085BD5Q38079565-0ECC2F02-A04A-493A-9235-98FF90B7FC35Q38464975-EB844287-157A-4427-8618-6D89924E3CC8Q38918821-9CF5582C-2593-4FA2-9FD2-8E45D46346B4Q39569545-D5311DBD-6570-4EBC-8056-B8E0397BA361Q39733221-EBF559C9-445F-469D-8DBB-DE08CD16BC26Q40279810-A145F31C-04A4-4C24-9478-A6AC96F146F9Q41671711-69CFCA84-3463-408B-A4A0-D4C767CA29DDQ42855410-FA1AB8AB-DE59-4CB5-9306-CDFA0F4B4EA0Q43545029-5F17D0A8-B11A-49FC-9A57-695B310783DAQ46240455-187D1174-5151-4609-8D50-869331AE70F1Q47322580-2C4F6974-056A-4E39-8633-EA4E78379E9CQ47366625-B00961D7-6AFF-47D9-A2A9-AC5F141369DBQ48097465-FF9C63E0-7C1A-4005-BD61-DCC31498B3B5Q48224247-59BE756A-7EDC-44A4-B73F-D3B4BAAE6F1CQ50067342-9B822FAA-AD87-4AE1-B89C-24E1AC75A575Q53147964-18708441-C105-4239-B1E7-FFEEFB9F67EBQ58774223-AB9D9001-5601-4A99-9CA9-86F96B80CE80
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Thrombosis in end-stage renal disease.
@ast
Thrombosis in end-stage renal disease.
@en
type
label
Thrombosis in end-stage renal disease.
@ast
Thrombosis in end-stage renal disease.
@en
prefLabel
Thrombosis in end-stage renal disease.
@ast
Thrombosis in end-stage renal disease.
@en
P2860
P1433
P1476
Thrombosis in end-stage renal disease.
@en
P2093
Laura M Dember
Liam F Casserly
P2860
P304
P356
10.1046/J.1525-139X.2003.16048.X
P577
2003-05-01T00:00:00Z